(Q61915138)
Statements
A Phase 1, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Single, Escalating Subcutaneous Doses Of PF-04603629 In Type 2 Diabetic Adult Subjects (English)
0 references
August 2007
0 references
71
0 references
18 year
0 references
70 year
0 references